适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 749
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40 Years 至 65 Years(—)
- 性别
- All
入选标准
- •men and women of all ethnical groups aged between 40 and 65 years
- •- treated by a general practitioner with a § 2 health insurance contract
- •- written consent to participate in the study
- •Presence of at least one of the following risk factors:
- •- arterial hypertension (documented diagnosis of hypertension for at least 3 months, defined as systolic blood pressure >140 and diastolic blood pressure >90 mmHg)
- •- diabetes mellitus (defined as Typ 1 and Typ 2)
- •- adipositas (defined as body mass index > 30 -g/m2)
- •- end stage renal disease in the familiy (family is defined as children, parents and siblings)
- •- history of cardiovascular diseases (stroke, transient ischemic attack (TIA), coronary heart disease, peripheral arterial disease)
排除标准
- •- prior recorded diagnosis of CKD (defined as a documentation of chronic kidney disease)
- •- prior participation in kidney.care” (recorded eGFR/ACR diagnosis according to kidney.care” in the outpatient setting)
- •- kidney transplant recipients
- •- dialysis patients
- •- participants with an eGFR < 15 ml/min/1.73 m2
- •- participants with acute serious illness
- •- carcinoma patients
- •- NYHA III and IV
- •- expected life expectancy < 6 months
- •- Unable or unwilling to give informed consent (If a person cannot communicate with staff, s/he is unable to provide informed consent.)
研究者
相似试验
进行中(未招募)
1 期
Gene Therapy for Crigler Najjar Syndromesevere Crigler Najjar syndrome in patients requiring phototherapyMedDRA version: 20.0Level: PTClassification code 10011386Term: Crigler-Najjar syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2017-000506-37-FRGenethon17
进行中(未招募)
1 期
Gene Therapy for Crigler Najjar Syndromesevere Crigler Najjar syndrome in patients requiring phototherapyMedDRA version: 20.0Level: PTClassification code 10011386Term: Crigler-Najjar syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2017-000506-37-NLGenethon17
进行中(未招募)
1 期
Gene Therapy for Crigler-Najjar SyndromeSevere Crigler Najjar syndrome in patients requiring daily phototherapy (= 6h/day)MedDRA version: 20.0Level: PTClassification code 10011386Term: Crigler-Najjar syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2017-000506-37-ITGENETHO17
尚未招募
2 期
Effectiveness of Malakudaara Mezhugu in the management of Kattu Mantham (Functional Constipation)CTRI/2023/07/055098Ayothidoss Pandithar Hospital, Ayothidoss Pandithar Hospital
招募中
不适用
A phase 2 study of GX-I7 in combination with bevacizumab in recurrent glioblastoma (GBM) patientsNeoplasmsKCT0006561The Catholic University of Korea, Seoul St. Mary's Hospital20
